Privia Health (PRVA) Revenue (2020 - 2026)

Privia Health's Revenue history runs 7 years deep, the most recent figure standing at $603.8 million for Q1 2026.

• On a quarterly basis, Revenue rose 25.78% year-over-year to $603.8 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 24.72% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 22.26% from the prior year.
• Revenue climbed to $603.8 million in Q1 2026 per PRVA's latest filing, from $541.2 million in the prior quarter.
• Across five years, Revenue topped out at $603.8 million in Q1 2026 and bottomed at $313.8 million in Q1 2022.
• The 5-year median for Revenue is $422.3 million (2024), against an average of $439.9 million.
• Across the five-year window, Revenue surged 48.63% in 2022 and increased 2.17% in 2024, its largest moves.
• Year by year, Revenue stood at $364.4 million in 2022, then rose by 20.97% to $440.8 million in 2023, then gained by 4.55% to $460.9 million in 2024, then rose by 17.42% to $541.2 million in 2025, then rose by 11.58% to $603.8 million in 2026.
• Per Business Quant, the three latest PRVA Revenue figures stand at $603.8 million (Q1 2026), $541.2 million (Q4 2025), and $580.4 million (Q3 2025).